Lipella Pharma receives US FDA nod for expanded access programme for LP-310, an oral rinse formulation to treat oral lichen planus: Pittsburgh Saturday, February 8, 2025, 09:00 Hr ...
Peethaambaran Kunnathoor, Chennai Saturday, February 8, 2025, 08:00 Hrs [IST] ...
Advanced therapies, medicines bring new hope for pulmonary hypertension patients: Dr Manisha Mendiratta: Shardul Nautiyal, Mumbai Saturday, February 8, 2025, 08:00 Hrs [IST] Dr Ma ...
Amit Upadhyay: Shardul Nautiyal, Mumbai Saturday, February 8, 2025, 08:00 Hrs [IST] For Indian doctors, nurses, and pharmacists as ...
India needs to develop strategies to mitigate the impact of USAID funding freeze: Nandita Vijayasimha, Bengaluru Saturday, February 8, 2025, 08:00 Hrs [IST] Indian pharmaceutical ...
The proposed budget allocation for the Central sector schemes of Department of Health Research (DHR), under the ministry of health and family welfare, is expected see an increase of almost 40 per cent ...
Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...
Equillium and Biocon announce positive data from phase 2 study of itolizumab to treat moderate to severe ulcerative colitis: Our Bureau, Bengaluru Friday, February 7, 2025, 10:30 ...
CIRM awards US$ 4 mn grant to Entos Pharma to advance development of ENTLEP001, a durable and redosable genetic medicine to treat CGL: San Diego Friday, February 7, 2025, 15:00 Hr ...
Actimed Therapeutics’ anti-catabolic and pro-anabolic transforming agent, S-pindolol benzoate receives US & European patents: London, UK Friday, February 7, 2025, 16:00 Hrs [IST ...
Sai Life Sciences in Q3 reports revenue of Rs. 439.8 crore with 14.6% growth; Net profit up 36% year-on-year: Our Bureau, Bengaluru Friday, February 7, 2025, 11:50 Hrs [IST] Sai L ...
Waters ElectroForce Apex 1 instrument offers increased speed to test advanced polymer materials: Our Bureau, Bengaluru Friday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results